Stock Quote

Corporate Developments and Future Plans

By: Issuewire

Scottsdale, Arizona May 20, 2021 (Issuewire.com) - Praxsyn Corporation's (OTC: PXYN, the "Company") subsidiary, Mesa Pharmacy, Inc., through its attorneys, had filed a Petition for Reconsideration of the Findings of Fact and Opinion on Decision regarding its pending litigation in California before the Workers' Compensation Appeals Board.  The Company is still currently awaiting a ruling on the Petition for Reconsideration.  However, notwithstanding the current lack of receipt of the ruling on the Petition for Reconsideration, the Company is proceeding with the preparation of an appeal to the California Courts of Appeal should the Petition for Reconsideration ultimately be denied.

 

About Praxsyn Corporation

Headquartered in Scottsdale, Arizona, Praxsyn Corporation works to realize the vision of medical professionals to improve the lives of their patients. Additional company information can be found at www.praxsyn.com.

Forward-Looking Statement This Press Release contains forward-looking statements that involve risks and uncertainties, which may include statements about business strategy and development plans, plans for entering a new business, anticipated sources of funds, including proceeds from future operations and plans, objectives, expectations, and intentions contained in the Press Release that are not historical facts such as "estimated gross"...prospective resources, total potential revenue, substantially exceeds, etc. "Because these forward-looking statements involve risk and uncertainties, actual results could differ materially from those discussed in this Press Release.

Media Contact

Praxsyn Corporation


d.oswald@praxsyncapital.com

4807888782

7904 E Chaparral Rd, Ste A110-210

http://praxsyn.com

Source :Mesa Pharmacy, Inc.

This article was originally published by IssueWire. Read the original article here.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.